Skip to main content
. 2023 Nov 17;10:1273156. doi: 10.3389/fcvm.2023.1273156

Table 2.

Comparison of accompanying symptoms between group A and group B.

Accompanying symptoms Group A (70 cases) Group B (124 cases) p
Fatigue, No. (%) 43 (61.43) 73 (58.87) 0.727
Cough, No. (%) 25 (35.71) 43 (34.68) 0.884
Memory impairment, No. (%) 19 (27.14) 26 (20.97) 0.328
Difficulty concentrating, No. (%) 16 (22.86) 20 (16.13) 0.247
Insomnia, No. (%) 13 (18.57) 19 (15.32) 0.558
Changes in the menstrual cycle, No. (%) 13 (18.57) 38 (30.65) 0.067
Chest distress, No. (%) 12 (17.14) 11 (8.87) 0.087
Headache, No. (%) 12 (17.14) 13 (10.48) 0.184
Shortness of breath, No. (%) 10 (14.29) 12 (9.68) 0.331
Vertigo, No. (%) 9 (12.86) 9 (7.26) 0.197
Hair loss, No. (%) 9 (12.86) 11 (8.87) 0.387
Joint or muscle pain, No. (%) 7 (10.00) 8 (6.45) 0.374
Drowsiness, No. (%) 7 (10.00) 5 (4.03) 0.098
Changes in smell or taste, No. (%) 7 (10.00) 18 (14.52) 0.367
Depression or anxiety, No. (%) 5 (7.14) 3 (3.42) 0.112
Chest pain, No. (%) 5 (7.14) 3 (3.42) 0.112
Rash, No. (%) 4 (5.71) 2 (1.61) 0.113
Pins and needles, No. (%) 2 (2.86) 1 (0.81) 0.266
Abdominal pain, No. (%) 2 (2.86) 1 (0.81) 0.266